Retractable Technologies, Inc. (AMEX: RVP) Stock Competitors & Peer Comparison
See RVP's competitors and their performance on the AMEX and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for RVP and its AMEX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RVP | $0.68 | +0.00% | 20.4M | -2.06 | -$0.33 | N/A |
| BDX | $156.36 | +2.22% | 56.6B | 11.62 | $13.45 | +2.39% |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.39% |
| MDLN | $38.75 | +2.98% | 32.8B | 45.06 | $0.86 | N/A |
| WST | $328.20 | -7.67% | 23.2B | 41.19 | $7.97 | +0.26% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| COO | $70.31 | +0.11% | 13.7B | 15.42 | $4.56 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.39% |
| BAX | $22.40 | +3.37% | 11.6B | 10.77 | $2.08 | +0.89% |
| ATR | $132.36 | +2.61% | 8.4B | 23.13 | $5.72 | +1.43% |
Stock Comparison
Becton, Dickinson and Company (NYSE: BDX)
RVP vs BDX Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, BDX has a market cap of 56.6B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while BDX trades at $156.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas BDX's P/E ratio is 11.62. In terms of profitability, RVP's ROE is -0.08%, compared to BDX's ROE of +0.05%. Regarding short-term risk, RVP is less volatile compared to BDX. This indicates lower risk in terms of short-term price fluctuations for RVP.Check BDX's competition here
Becton, Dickinson and Company (NYSE: BDXA)
RVP vs BDXA Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas BDXA's P/E ratio is 45.70. In terms of profitability, RVP's ROE is -0.08%, compared to BDXA's ROE of +0.05%. Regarding short-term risk, RVP is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for RVP.Check BDXA's competition here
Medline Inc. (NASDAQ: MDLN)
RVP vs MDLN Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, MDLN has a market cap of 32.8B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while MDLN trades at $38.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas MDLN's P/E ratio is 45.06. In terms of profitability, RVP's ROE is -0.08%, compared to MDLN's ROE of +0.07%. Regarding short-term risk, RVP is less volatile compared to MDLN. This indicates lower risk in terms of short-term price fluctuations for RVP.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
RVP vs WST Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, WST has a market cap of 23.2B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while WST trades at $328.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas WST's P/E ratio is 41.19. In terms of profitability, RVP's ROE is -0.08%, compared to WST's ROE of +0.19%. Regarding short-term risk, RVP is less volatile compared to WST. This indicates lower risk in terms of short-term price fluctuations for RVP.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
RVP vs HOLX Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas HOLX's P/E ratio is 31.54. In terms of profitability, RVP's ROE is -0.08%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, RVP is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for RVP.Check HOLX's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
RVP vs COO Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, COO has a market cap of 13.7B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while COO trades at $70.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas COO's P/E ratio is 15.42. In terms of profitability, RVP's ROE is -0.08%, compared to COO's ROE of +0.03%. Regarding short-term risk, RVP is less volatile compared to COO. This indicates lower risk in terms of short-term price fluctuations for RVP.Check COO's competition here
Becton, Dickinson and Company (NYSE: BDXB)
RVP vs BDXB Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas BDXB's P/E ratio is 7.60. In terms of profitability, RVP's ROE is -0.08%, compared to BDXB's ROE of +0.05%. Regarding short-term risk, RVP is less volatile compared to BDXB. This indicates lower risk in terms of short-term price fluctuations for RVP.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
RVP vs BAX Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, BAX has a market cap of 11.6B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while BAX trades at $22.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas BAX's P/E ratio is 10.77. In terms of profitability, RVP's ROE is -0.08%, compared to BAX's ROE of -0.16%. Regarding short-term risk, RVP is less volatile compared to BAX. This indicates lower risk in terms of short-term price fluctuations for RVP.Check BAX's competition here
AptarGroup, Inc. (NYSE: ATR)
RVP vs ATR Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, ATR has a market cap of 8.4B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while ATR trades at $132.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas ATR's P/E ratio is 23.13. In terms of profitability, RVP's ROE is -0.08%, compared to ATR's ROE of +0.14%. Regarding short-term risk, RVP is less volatile compared to ATR. This indicates lower risk in terms of short-term price fluctuations for RVP.Check ATR's competition here
Avantor, Inc. (NYSE: AVTR)
RVP vs AVTR Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, AVTR has a market cap of 7.8B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while AVTR trades at $11.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas AVTR's P/E ratio is 13.46. In terms of profitability, RVP's ROE is -0.08%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, RVP is less volatile compared to AVTR. This indicates lower risk in terms of short-term price fluctuations for RVP.Check AVTR's competition here
Repligen Corporation (NASDAQ: RGEN)
RVP vs RGEN Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, RGEN has a market cap of 7.4B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while RGEN trades at $131.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas RGEN's P/E ratio is 73.31. In terms of profitability, RVP's ROE is -0.08%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, RVP is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for RVP.Check RGEN's competition here
Teleflex Incorporated (NYSE: TFX)
RVP vs TFX Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, TFX has a market cap of 5.8B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while TFX trades at $132.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas TFX's P/E ratio is 12.32. In terms of profitability, RVP's ROE is -0.08%, compared to TFX's ROE of -0.28%. Regarding short-term risk, RVP is less volatile compared to TFX. This indicates lower risk in terms of short-term price fluctuations for RVP.Check TFX's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
RVP vs BLCO Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, BLCO has a market cap of 5.8B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while BLCO trades at $16.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas BLCO's P/E ratio is 24.88. In terms of profitability, RVP's ROE is -0.08%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, RVP is less volatile compared to BLCO. This indicates lower risk in terms of short-term price fluctuations for RVP.Check BLCO's competition here
Stevanato Group S.p.A. (NYSE: STVN)
RVP vs STVN Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, STVN has a market cap of 5.4B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while STVN trades at $19.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas STVN's P/E ratio is 31.81. In terms of profitability, RVP's ROE is -0.08%, compared to STVN's ROE of +0.10%. Regarding short-term risk, RVP is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for RVP.Check STVN's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
RVP vs MMSI Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, MMSI has a market cap of 4.4B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while MMSI trades at $74.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas MMSI's P/E ratio is 19.01. In terms of profitability, RVP's ROE is -0.08%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, RVP is less volatile compared to MMSI. This indicates lower risk in terms of short-term price fluctuations for RVP.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
RVP vs ICUI Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, ICUI has a market cap of 3.9B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while ICUI trades at $157.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas ICUI's P/E ratio is 19.66. In terms of profitability, RVP's ROE is -0.08%, compared to ICUI's ROE of +0.02%. Regarding short-term risk, RVP is less volatile compared to ICUI. This indicates lower risk in terms of short-term price fluctuations for RVP.Check ICUI's competition here
Haemonetics Corporation (NYSE: HAE)
RVP vs HAE Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, HAE has a market cap of 3.6B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while HAE trades at $78.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas HAE's P/E ratio is 15.86. In terms of profitability, RVP's ROE is -0.08%, compared to HAE's ROE of +0.11%. Regarding short-term risk, RVP is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for RVP.Check HAE's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
RVP vs XRAY Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, XRAY has a market cap of 2.6B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while XRAY trades at $12.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas XRAY's P/E ratio is 9.04. In terms of profitability, RVP's ROE is -0.08%, compared to XRAY's ROE of -0.41%. Regarding short-term risk, RVP is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for RVP.Check XRAY's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
RVP vs LMAT Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, LMAT has a market cap of 2.2B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while LMAT trades at $95.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas LMAT's P/E ratio is 37.05. In terms of profitability, RVP's ROE is -0.08%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, RVP is less volatile compared to LMAT. This indicates lower risk in terms of short-term price fluctuations for RVP.Check LMAT's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
RVP vs PLSE Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, PLSE has a market cap of 2.1B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while PLSE trades at $30.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas PLSE's P/E ratio is -27.48. In terms of profitability, RVP's ROE is -0.08%, compared to PLSE's ROE of -0.87%. Regarding short-term risk, RVP is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for RVP.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
RVP vs ATRC Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, ATRC has a market cap of 1.8B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while ATRC trades at $35.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas ATRC's P/E ratio is 1088.20. In terms of profitability, RVP's ROE is -0.08%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, RVP is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for RVP.Check ATRC's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
RVP vs BLFS Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, BLFS has a market cap of 1.5B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while BLFS trades at $29.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas BLFS's P/E ratio is -141.85. In terms of profitability, RVP's ROE is -0.08%, compared to BLFS's ROE of -0.03%. Regarding short-term risk, RVP is less volatile compared to BLFS. This indicates lower risk in terms of short-term price fluctuations for RVP.Check BLFS's competition here
Azenta, Inc. (NASDAQ: AZTA)
RVP vs AZTA Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, AZTA has a market cap of 1.3B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while AZTA trades at $27.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas AZTA's P/E ratio is 60.82. In terms of profitability, RVP's ROE is -0.08%, compared to AZTA's ROE of -0.11%. Regarding short-term risk, RVP is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for RVP.Check AZTA's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
RVP vs KMTS Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, KMTS has a market cap of 1.2B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while KMTS trades at $21.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas KMTS's P/E ratio is -8.92. In terms of profitability, RVP's ROE is -0.08%, compared to KMTS's ROE of -0.59%. Regarding short-term risk, RVP is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for RVP.Check KMTS's competition here
STAAR Surgical Company (NASDAQ: STAA)
RVP vs STAA Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, STAA has a market cap of 1.2B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while STAA trades at $23.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas STAA's P/E ratio is 41.02. In terms of profitability, RVP's ROE is -0.08%, compared to STAA's ROE of -0.06%. Regarding short-term risk, RVP is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for RVP.Check STAA's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
RVP vs QDEL Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, QDEL has a market cap of 1.1B. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while QDEL trades at $16.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas QDEL's P/E ratio is 11.98. In terms of profitability, RVP's ROE is -0.08%, compared to QDEL's ROE of -0.56%. Regarding short-term risk, RVP is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for RVP.Check QDEL's competition here
Atrion Corporation (NASDAQ: ATRI)
RVP vs ATRI Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas ATRI's P/E ratio is 64.50. In terms of profitability, RVP's ROE is -0.08%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, RVP is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for RVP.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
RVP vs ANGO Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, ANGO has a market cap of 561.7M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while ANGO trades at $13.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas ANGO's P/E ratio is -34.85. In terms of profitability, RVP's ROE is -0.08%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, RVP is less volatile compared to ANGO. This indicates lower risk in terms of short-term price fluctuations for RVP.Check ANGO's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
RVP vs NNNN Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, NNNN has a market cap of 441.5M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while NNNN trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas NNNN's P/E ratio is 145.38. In terms of profitability, RVP's ROE is -0.08%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, RVP is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for RVP.Check NNNN's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
RVP vs OSUR Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, OSUR has a market cap of 273.3M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while OSUR trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas OSUR's P/E ratio is -4.78. In terms of profitability, RVP's ROE is -0.08%, compared to OSUR's ROE of -0.21%. Regarding short-term risk, RVP is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for RVP.Check OSUR's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
RVP vs SMTI Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, SMTI has a market cap of 234.2M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while SMTI trades at $25.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas SMTI's P/E ratio is -426.00. In terms of profitability, RVP's ROE is -0.08%, compared to SMTI's ROE of -2.46%. Regarding short-term risk, RVP is less volatile compared to SMTI. This indicates lower risk in terms of short-term price fluctuations for RVP.Check SMTI's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
RVP vs UTMD Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, UTMD has a market cap of 213.8M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while UTMD trades at $67.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas UTMD's P/E ratio is 19.86. In terms of profitability, RVP's ROE is -0.08%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, RVP is less volatile compared to UTMD. This indicates lower risk in terms of short-term price fluctuations for RVP.Check UTMD's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
RVP vs INFU Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, INFU has a market cap of 183.9M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while INFU trades at $9.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas INFU's P/E ratio is 23.97. In terms of profitability, RVP's ROE is -0.08%, compared to INFU's ROE of +0.14%. Regarding short-term risk, RVP is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for RVP.Check INFU's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
RVP vs KRMD Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, KRMD has a market cap of 175.9M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while KRMD trades at $3.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas KRMD's P/E ratio is -95.75. In terms of profitability, RVP's ROE is -0.08%, compared to KRMD's ROE of -0.14%. Regarding short-term risk, RVP is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for RVP.Check KRMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
RVP vs PDEX Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, PDEX has a market cap of 175.4M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while PDEX trades at $54.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas PDEX's P/E ratio is 19.34. In terms of profitability, RVP's ROE is -0.08%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, RVP is less volatile compared to PDEX. This indicates lower risk in terms of short-term price fluctuations for RVP.Check PDEX's competition here
Microbot Medical Inc. (NASDAQ: MBOT)
RVP vs MBOT Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, MBOT has a market cap of 77.9M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while MBOT trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas MBOT's P/E ratio is -6.58. In terms of profitability, RVP's ROE is -0.08%, compared to MBOT's ROE of -0.22%. Regarding short-term risk, RVP is less volatile compared to MBOT. This indicates lower risk in terms of short-term price fluctuations for RVP.Check MBOT's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
RVP vs AKYA Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas AKYA's P/E ratio is -1.34. In terms of profitability, RVP's ROE is -0.08%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, RVP is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for RVP.Check AKYA's competition here
SkyAI, Inc. (NASDAQ: STSS)
RVP vs STSS Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, STSS has a market cap of 58.4M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while STSS trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas STSS's P/E ratio is -0.02. In terms of profitability, RVP's ROE is -0.08%, compared to STSS's ROE of -1.66%. Regarding short-term risk, RVP is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for RVP.Check STSS's competition here
Daxor Corporation (NASDAQ: DXR)
RVP vs DXR Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, DXR has a market cap of 52.7M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while DXR trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas DXR's P/E ratio is 27.33. In terms of profitability, RVP's ROE is -0.08%, compared to DXR's ROE of +0.22%. Regarding short-term risk, RVP is less volatile compared to DXR. This indicates lower risk in terms of short-term price fluctuations for RVP.Check DXR's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
RVP vs OMIC Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas OMIC's P/E ratio is -0.58. In terms of profitability, RVP's ROE is -0.08%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, RVP is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for RVP.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
RVP vs IGAP Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas IGAP's P/E ratio is -10.52. In terms of profitability, RVP's ROE is -0.08%, compared to IGAP's ROE of -0.86%. Regarding short-term risk, RVP is less volatile compared to IGAP. This indicates lower risk in terms of short-term price fluctuations for RVP.Check IGAP's competition here
Nephros, Inc. (NASDAQ: NEPH)
RVP vs NEPH Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, NEPH has a market cap of 38.6M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while NEPH trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas NEPH's P/E ratio is 50.86. In terms of profitability, RVP's ROE is -0.08%, compared to NEPH's ROE of +0.08%. Regarding short-term risk, RVP is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for RVP.Check NEPH's competition here
Milestone Scientific Inc. (AMEX: MLSS)
RVP vs MLSS Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, MLSS has a market cap of 34.5M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while MLSS trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas MLSS's P/E ratio is -6.50. In terms of profitability, RVP's ROE is -0.08%, compared to MLSS's ROE of -1.66%. Regarding short-term risk, RVP is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for RVP.Check MLSS's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
RVP vs POCI Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, POCI has a market cap of 33.8M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while POCI trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas POCI's P/E ratio is -6.07. In terms of profitability, RVP's ROE is -0.08%, compared to POCI's ROE of -0.37%. Regarding short-term risk, RVP is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for RVP.Check POCI's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
RVP vs SDC Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas SDC's P/E ratio is -0.03. In terms of profitability, RVP's ROE is -0.08%, compared to SDC's ROE of -1.96%. Regarding short-term risk, RVP is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for RVP.Check SDC's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
RVP vs HBIO Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, HBIO has a market cap of 27.3M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while HBIO trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas HBIO's P/E ratio is -16.81. In terms of profitability, RVP's ROE is -0.08%, compared to HBIO's ROE of -0.73%. Regarding short-term risk, RVP is less volatile compared to HBIO. This indicates lower risk in terms of short-term price fluctuations for RVP.Check HBIO's competition here
Invacare Corporation (NYSE: IVC)
RVP vs IVC Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas IVC's P/E ratio is -0.79. In terms of profitability, RVP's ROE is -0.08%, compared to IVC's ROE of -0.46%. Regarding short-term risk, RVP is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for RVP.Check IVC's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
RVP vs ZJYL Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, ZJYL has a market cap of 16M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while ZJYL trades at $2.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas ZJYL's P/E ratio is 12.75. In terms of profitability, RVP's ROE is -0.08%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, RVP is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for RVP.Check ZJYL's competition here
Femasys Inc. (NASDAQ: FEMY)
RVP vs FEMY Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, FEMY has a market cap of 11.2M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while FEMY trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas FEMY's P/E ratio is -10.25. In terms of profitability, RVP's ROE is -0.08%, compared to FEMY's ROE of -2.58%. Regarding short-term risk, RVP is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for RVP.Check FEMY's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
RVP vs RGNT Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, RGNT has a market cap of 7.8M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while RGNT trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas RGNT's P/E ratio is -0.08. In terms of profitability, RVP's ROE is -0.08%, compared to RGNT's ROE of N/A. Regarding short-term risk, RVP is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for RVP.Check RGNT's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
RVP vs NSTG Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas NSTG's P/E ratio is -0.03. In terms of profitability, RVP's ROE is -0.08%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, RVP is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for RVP.Check NSTG's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
RVP vs NXGL Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, NXGL has a market cap of 4M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while NXGL trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas NXGL's P/E ratio is -1.13. In terms of profitability, RVP's ROE is -0.08%, compared to NXGL's ROE of -0.70%. Regarding short-term risk, RVP is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for RVP.Check NXGL's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
RVP vs POAI Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas POAI's P/E ratio is -0.03. In terms of profitability, RVP's ROE is -0.08%, compared to POAI's ROE of -107.05%. Regarding short-term risk, RVP is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for RVP.Check POAI's competition here
Lucyd, Inc (NASDAQ: LUCY)
RVP vs LUCY Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, LUCY has a market cap of 2.6M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while LUCY trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas LUCY's P/E ratio is -0.39. In terms of profitability, RVP's ROE is -0.08%, compared to LUCY's ROE of -0.83%. Regarding short-term risk, RVP is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for RVP.Check LUCY's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
RVP vs MHUA Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas MHUA's P/E ratio is 0.25. In terms of profitability, RVP's ROE is -0.08%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, RVP is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for RVP.Check MHUA's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
RVP vs NXGLW Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, NXGLW has a market cap of 1.8M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while NXGLW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas NXGLW's P/E ratio is -0.06. In terms of profitability, RVP's ROE is -0.08%, compared to NXGLW's ROE of -0.70%. Regarding short-term risk, RVP is more volatile compared to NXGLW. This indicates higher risk in terms of short-term price fluctuations for RVP.Check NXGLW's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
RVP vs GMVD Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas GMVD's P/E ratio is -0.01. In terms of profitability, RVP's ROE is -0.08%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, RVP is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for RVP.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
RVP vs GMVDW Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas GMVDW's P/E ratio is N/A. In terms of profitability, RVP's ROE is -0.08%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, RVP is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for RVP.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
RVP vs AVGR Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas AVGR's P/E ratio is -0.05. In terms of profitability, RVP's ROE is -0.08%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, RVP is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for RVP.Check AVGR's competition here
Lucyd, Inc (NASDAQ: LUCYW)
RVP vs LUCYW Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas LUCYW's P/E ratio is -0.00. In terms of profitability, RVP's ROE is -0.08%, compared to LUCYW's ROE of -0.83%. Regarding short-term risk, RVP is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for RVP.Check LUCYW's competition here
GlucoTrack, Inc. (NASDAQ: GCTK)
RVP vs GCTK Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, GCTK has a market cap of 165.2K. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while GCTK trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas GCTK's P/E ratio is -0.01. In terms of profitability, RVP's ROE is -0.08%, compared to GCTK's ROE of -5.82%. Regarding short-term risk, RVP is less volatile compared to GCTK. This indicates lower risk in terms of short-term price fluctuations for RVP.Check GCTK's competition here
Apria, Inc. (NASDAQ: APR)
RVP vs APR Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, APR has a market cap of 0. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas APR's P/E ratio is 22.59. In terms of profitability, RVP's ROE is -0.08%, compared to APR's ROE of +9.81%. Regarding short-term risk, RVP is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for RVP.Check APR's competition here
IntriCon Corporation (NASDAQ: IIN)
RVP vs IIN Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, IIN has a market cap of 0. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas IIN's P/E ratio is 226.45. In terms of profitability, RVP's ROE is -0.08%, compared to IIN's ROE of -0.00%. Regarding short-term risk, RVP is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for RVP.Check IIN's competition here
Analogic Corporation (NASDAQ: ALOG)
RVP vs ALOG Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, ALOG has a market cap of 0. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas ALOG's P/E ratio is 40.93. In terms of profitability, RVP's ROE is -0.08%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, RVP is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for RVP.Check ALOG's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
RVP vs ATRS Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, ATRS has a market cap of 0. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas ATRS's P/E ratio is 14.95. In terms of profitability, RVP's ROE is -0.08%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, RVP is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for RVP.Check ATRS's competition here
Invuity, Inc. (NASDAQ: IVTY)
RVP vs IVTY Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, IVTY has a market cap of 0. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas IVTY's P/E ratio is -3.80. In terms of profitability, RVP's ROE is -0.08%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, RVP is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for RVP.Check IVTY's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
RVP vs HRC Comparison July 2026
Retractable Technologies, Inc. (AMEX: RVP) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVP stands at 20.4M. In comparison, HRC has a market cap of 0. Regarding current trading prices, RVP is priced at $0.68 on the AMEX, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVP currently has a P/E ratio of -2.06, whereas HRC's P/E ratio is 41.92. In terms of profitability, RVP's ROE is -0.08%, compared to HRC's ROE of +0.14%. Regarding short-term risk, RVP is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for RVP.Check HRC's competition here